Annals of Surgical Oncology, Vol 6, Issue 4 398-404, Copyright © 1999 by Society of Surgical Oncology

ARTICLES

Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma

J. D. Wagner, D. Davidson, J. J. Coleman 3rd, G. Hutchins, D. Schauwecker, H. M. Park and R. J. Havlik
Department of Surgery, Indiana University School of Medicine, Indiana University Purdue University at Indianapolis, USA.

BACKGROUND: Regional lymph node tumor volumes in patients undergoing sentinel lymph node (SN) biopsy (SNB) for treatment of cutaneous melanoma have not been described. The objectives of this study were to describe the lymph node tumor volumes typically seen in this population and to correlate tumor volumes with tumor thickness and positive SN characteristics. METHODS: Review of a consecutive series of patients with clinically localized cutaneous melanoma who underwent SNB of nonpalpable regional lymph node basins followed by complete lymphadenectomy (LND) was performed. Multiple lymph node sections from positive SNs and nonsentinel nodes (NSNs) in LND specimens were examined microscopically. Individual tumor deposit diameters were measured using an ocular micrometer. Aggregate tumor volumes were calculated for SN and LND specimens. Tumor volumes and SN and LND positivity rates were correlated with tumor thickness, the number of positive SNs, and the presence of multiple SN tumor deposits. RESULTS: SNB procedures were performed for 149 melanomas in 189 regional nodal basins. The mean tumor depth was 2.48 mm. The mean number of SNs/basin was 2.1. Thirty-two of 149 SNB procedures (21.5%) revealed a total of 34 nodal basins with at least one positive SN. The median tumor volume in positive SNs was 4.7 mm3 (range, 0.1-3618 mm3; mean, 209 mm3). The median aggregate tumor volume in positive LND specimens was 4.9 mm3 (range, 0.1-3618 mm3; mean, 224 mm3). Six basins (17.6%) contained at least one positive NSN. The regional node aggregate tumor volume correlated weakly with tumor thickness (Pearson's correlation coefficient = .302, P = .0934). NSN positivity was not predicted by tumor thickness, American Joint Committee on Cancer tumor stage, number of positive SNs, or number of metastatic deposits within SNs. CONCLUSIONS: Most melanoma-positive SNs contain minute tumor volumes. Tumor thickness and patterns of SN metastases may not be predictive of tumor burden or the presence of positive NSNs.

This article has been cited by other articles:

				J. E. Gershenwald, R. H.I. Andtbacka, V. G. Prieto, M. M. Johnson, A. H. Diwan, J. E. Lee, P. F. Mansfield, J. N. Cormier, C. W. Schacherer, and M. I. Ross Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With Melanoma J. Clin. Oncol., September 10, 2008; 26(26): 4296 - 4303. [Abstract] [Full Text] [PDF]

				I. Satzger, B. Volker, A. Meier, A. Kapp, and R. Gutzmer Criteria in Sentinel Lymph Nodes of Melanoma Patients that Predict Involvement of Nonsentinel Lymph Nodes Ann. Surg. Oncol., June 1, 2008; 15(6): 1723 - 1732. [Abstract] [Full Text] [PDF]

				T. Z. Belhocine, A. M. Scott, E. Even-Sapir, J.-L. Urbain, and R. Essner Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma J. Nucl. Med., June 1, 2006; 47(6): 957 - 967. [Abstract] [Full Text] [PDF]

				M. I. Ross Early-stage melanoma: staging criteria and prognostic modeling. Clin. Cancer Res., April 1, 2006; 12(7): 2312s - 2319s. [Abstract] [Full Text] [PDF]

				R. J. C. L. M. Vuylsteke, P. J. Borgstein, P. A. M. van Leeuwen, H. A. Gietema, B. G. Molenkamp, M. G. S. Muller, P. J. van Diest, J. R. M. van der Sijp, and S. Meijer Sentinel Lymph Node Tumor Load: An Independent Predictor of Additional Lymph Node Involvement and Survival in Melanoma Ann. Surg. Oncol., June 1, 2005; 12(6): 440 - 448. [Abstract] [Full Text] [PDF]

				A. J. Cochran, A. Roberts, D.-R. Wen, R.-R. Huang, E. Itakura, F. Luo, and S. W. Binder Optimized Assessment of Sentinel Lymph Nodes for Metastatic Melanoma: Implications for Regional Surgery and Overall Treatment Planning Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 156S - 161S. [Abstract] [Full Text] [PDF]

				C A Murray, W L Leong, D R McCready, and D M Ghazarian Histopathological patterns of melanoma metastases in sentinel lymph nodes J. Clin. Pathol., January 1, 2004; 57(1): 64 - 67. [Abstract] [Full Text] [PDF]

				G. W. Carlson, D. R. Murray, R. H. Lyles, C. A. Staley, A. Hestley, and C. Cohen The Amount of Metastatic Melanoma in a Sentinel Lymph Node: Does It Have Prognostic Significance? Ann. Surg. Oncol., June 1, 2003; 10(5): 575 - 581. [Abstract] [Full Text] [PDF]

				J. D. Wagner PET Detection of Melanoma Metastases in Lymph Nodes J. Nucl. Med., March 1, 2003; 44(3): 486 - 486. [Full Text]

				C. E. Schmalbach, B. Nussenbaum, R. S. Rees, J. Schwartz, T. M. Johnson, and C. R. Bradford Reliability of Sentinel Lymph Node Mapping With Biopsy for Head and Neck Cutaneous Melanoma Arch Otolaryngol Head Neck Surg, January 1, 2003; 129(1): 61 - 65. [Abstract] [Full Text] [PDF]

				J. M. Ranieri, J. D. Wagner, R. Azuaje, D. Davidson, S. Wenck, J. Fyffe, and J. J. Coleman III Prognostic Importance of Lymph Node Tumor Burden in Melanoma Patients Staged by Sentinel Node Biopsy Ann. Surg. Oncol., December 1, 2002; 9(10): 975 - 981. [Abstract] [Full Text] [PDF]

				K. M. McMasters, S. L. Wong, M. J. Edwards, C. Chao, M. I. Ross, R. D. Noyes, V. Viar, P. B. Cerrito, and D. S. Reintgen Frequency of Nonsentinel Lymph Node Metastasis in Melanoma Ann. Surg. Oncol., March 1, 2002; 9(2): 137 - 141. [Abstract] [Full Text] [PDF]

				C. M. Balch, S.-J. Soong, J. E. Gershenwald, J. F. Thompson, D. S. Reintgen, N. Cascinelli, M. Urist, K. M. McMasters, M. I. Ross, J. M. Kirkwood, et al. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System J. Clin. Oncol., August 15, 2001; 19(16): 3622 - 3634. [Abstract] [Full Text] [PDF]

				C. M. Balch, A. C. Buzaid, S.-J. Soong, M. B. Atkins, N. Cascinelli, D. G. Coit, I. D. Fleming, J. E. Gershenwald, A. Houghton Jr, J. M. Kirkwood, et al. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma J. Clin. Oncol., August 15, 2001; 19(16): 3635 - 3648. [Abstract] [Full Text] [PDF]

				J. D. Wagner, H.-M. Park, J. J. Coleman III, C. Love, and J. T. Hayes Cervical Sentinel Lymph Node Biopsy for Melanomas of the Head and Neck and Upper Thorax Arch Otolaryngol Head Neck Surg, March 1, 2000; 126(3): 313 - 321. [Abstract] [Full Text] [PDF]